• Shop
  • My Account
    • Cart
    • Checkout
healthtopical
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!
  • Privacy Policy
No Result
View All Result
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!
  • Privacy Policy
No Result
View All Result
healthtopical
No Result
View All Result
Home Drug

Suven Gets Patent For Neuro Drugs From Canada, Hong Kong

Sristy by Sristy
July 7, 2016
in Drug
0 0
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Suven Gets Patent For Neuro Drugs From Canada, Hong Kong

New Delhi: Drug firm Suven Life Sciences has received a patent each from Canada and Hong Kong for molecules to be developed as drugs for treatment of various central nervous system disorders.

The product patents are “valid through 2032 and 2030, respectively,” Suven Life Sciences said in a filing to BSE.

With these new patents, the company has a total of 23 patents from Canada and 20 patents from Hong Kong, it added.

The new chemical entities (NCEs) are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders such as Alzheimer’s disease, Parkinson and Schizophrenia, Suven Life Sciences said.

“We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,” Suven CEO Venkat Jasti said.

“The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents…,” Suven Life Sciences said.

Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II, it added.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Story first published on: June 14, 2016 16:48 (IST)

Tags: Suven Life Sciences, Alzheimer’s disease, Schizophrenia, neuro-degenerative disorders

[“source-ndtv”]

Tags: Canadadrugs:forFromGetsHongKongNeuroPatentSuven
Previous Post

Second Season of Narcos to Premiere in September

Next Post

Diabetes Drug May Lower Risk Of Heart Attack, Stroke: Study

Next Post
Diabetes Drug May Lower Risk Of Heart Attack, Stroke: Study

Diabetes Drug May Lower Risk Of Heart Attack, Stroke: Study

No Result
View All Result

Get Daily Update Via Mail

Follow me on Twitter

My Tweets

Like Us !

Like Us !
  • Home
  • Privacy Policy
  • Contact Us!

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Diet
  • Excercise
    • Yoga
  • Drug
  • Cancer
  • Eyes
  • Stretch Marks
  • Skin
  • Hair Loss
  • News
  • Contact Us!
  • Privacy Policy

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In